About the 6-Minute Walk Test
The 6MWT is a sub-maximal functional exercise test introduced in pulmonary rehabilitation and adopted across cardiology, pulmonology and transplant medicine. The patient walks at their own pace on a flat 30-metre track for 6 minutes; the total distance is recorded. The ATS 2002 statement standardised the protocol with rest periods, verbal encouragement scripts, baseline and end-test vital signs, and dyspnea ratings. Reproducibility within an individual is typically ±20 m once a learning-effect baseline is established.
How the math works
- Convert height to centimetres and weight to kilograms.
- Apply the sex-specific Enright-Sherrill equation to compute the predicted distance.
- Subtract the sex-specific residual (153 m male, 139 m female) to get the LLN.
- Compare observed vs predicted as a percentage and assign a severity bucket: >= 82% normal, 70-82% mildly reduced, 60-70% moderately reduced, < 60% severely reduced.
- Add clinical-context flags based on absolute distance for COPD, CHF, pulmonary hypertension and transplant criteria.
- Compute heart-rate rise vs (220 - age) - resting HR to detect chronotropic incompetence; flag SpO2 drop >= 4% as significant exercise desaturation.
Predicted distance by age and sex
Reference table at 170 cm height and 75 kg weight using the Enright-Sherrill equations:
| Age | Male predicted | Male LLN | Female predicted | Female LLN |
|---|---|---|---|---|
| 40 | 610 m | 457 m | 553 m | 414 m |
| 50 | 560 m | 407 m | 495 m | 356 m |
| 60 | 510 m | 357 m | 437 m | 298 m |
| 70 | 460 m | 307 m | 380 m | 241 m |
| 80 | 410 m | 257 m | 322 m | 183 m |
Values rounded to nearest metre. Use the calculator above for the exact predicted distance at the patient's actual height and weight.
Clinical cutoffs by condition
How absolute 6MWT distance maps to prognosis in common diseases. Compare the patient's observed distance against these thresholds:
Percent predicted bands
Visual mapping of percent-predicted to severity classification:
Worked example: 60-year-old man, 175 cm, 80 kg, walked 450 m
Using the defaults shown in the calculator above, here is the step-by-step.
- Predicted distance: 7.57 × 175 - 5.02 × 60 - 1.76 × 80 - 309 = 1324.75 - 301.2 - 140.8 - 309 = 573.75 m, rounded to 574 m.
- Lower limit of normal: 574 - 153 = 421 m.
- Percent predicted: 450 ÷ 574 × 100 = 78.4%. Falls in the 70-82% mildly reduced band.
- Heart-rate response: end-test 118 bpm minus resting 78 bpm = 40 bpm rise. Age-predicted max HR = 220 - 60 = 160. HR reserve = 160 - 78 = 82. Percent of reserve = 40 ÷ 82 = 49%. Below 60% suggests possible chronotropic limitation.
- SpO2 drop: 97% to 94% = 3 percentage points. Below the 4-point exercise-desaturation threshold but worth tracking on repeat tests.
- Borg dyspnea: 4 / 10 (somewhat severe) post-test. Reasonable effort.
- Clinical context: 450 m is above the COPD 350-m and CHF 300-m cutoffs, and above the 400-m lung-transplant threshold. Below 500-m healthy-normal mark but consistent with mild functional limitation.
- Calorie estimate: walking at 4.5 km/h represents roughly 3.5 MET, so an 80 kg adult expends ~28 kcal over 6 minutes. Trivial energetically; useful as a planning anchor only.
Interpreting deeper: HR response and Borg dyspnea
Distance alone underspecifies the patient. Two patients with identical 6MWT distance can have very different clinical pictures depending on heart-rate response and breathlessness:
| Pattern | Distance | HR response | Borg | Likely picture |
|---|---|---|---|---|
| Deconditioning | 350-500 m | Normal rise (>60% reserve) | 2-4 | Trainable. Refer to cardiac/pulm rehab. |
| Ventilatory limit (COPD) | < 350 m | Modest rise | 6-8 | Desaturation likely. Consider O2 + bronchodilator review. |
| Cardiac limit (CHF) | < 300 m | Blunted rise | 4-6 | Likely NYHA III/IV. Optimise GDMT, consider diuretic trial. |
| Severe PH | < 250 m | Blunted, often desaturates | 7-10 | High mortality marker. PH-centre referral. |
What changes the test result
- Track shape and length: 30-metre straight tracks are standard. Shorter circuits underestimate distance by 5-10% due to extra turn time. Avoid hospital corridors with bends.
- Verbal encouragement: standardise to ATS script. Untimed encouragement can add 30 m. Cheerleading invalidates the test.
- Learning effect: the second test exceeds the first by ~25 m on average. ATS recommends two tests separated by 30 minutes, taking the higher distance.
- Time of day: COPD patients walk further later in the morning after their bronchodilator has fully kicked in. Schedule consistently for serial tests.
- Mood and motivation: distance can drop 30-50 m in depressed or unmotivated patients. Document patient state at test start.
Minimal clinically important difference (MCID)
A change of 30 metres on serial 6MWT is the accepted MCID across COPD, CHF and pulmonary hypertension trials. Improvements below 30 m are within test-retest variability. Improvements of 50-80 m typically reflect meaningful response to therapy (pulmonary rehab, optimised GDMT, PH-specific therapy). A drop of 30 m or more on a stable patient warrants clinical review for disease progression, deconditioning or new comorbidity.
Putting it together for a clinic report
A complete ATS 6MWT report should include all of the following:
- Distance walked (m), percent predicted vs Enright-Sherrill, comparison to LLN.
- Heart rate, BP and SpO2 at rest and at end of test (and at 1-minute recovery if equipment allows).
- Borg dyspnea and Borg leg fatigue, pre and post.
- Number of stops, total stop time, and any early termination reason.
- Use and flow rate of supplemental oxygen, if any.
- Test order (first vs second of the day) for learning-effect interpretation.
- Free-text technician note on patient effort, gait, and any adverse events.
The formula explained
This calculator applies four chained equations:
1. Male predicted = 7.57 × H_cm − 5.02 × A − 1.76 × W_kg − 309
2. Female predicted = 2.11 × H_cm − 2.29 × W_kg − 5.78 × A + 667
3. LLN = predicted − 153 (male) or − 139 (female)
4. % predicted = observed ÷ predicted × 100
These rules come from Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998;158:1384-1387 (n=290 healthy adults, ages 40-80). The ATS 2002 statement endorsed Enright-Sherrill as the default reference equation for North American populations; some European labs prefer Troosters 1999. Both produce predicted distances within ±50 m of each other for typical adults.
To verify: plug in (male, 60 y, 175 cm, 80 kg, 450 m). Predicted should equal 573.75 m, LLN 420.75 m, percent predicted 78.4%.
Frequently asked questions
What is a normal 6-minute walk test distance?
A 6MWT at or above 82% of the Enright-Sherrill predicted distance is considered normal. The absolute predicted depends on age, sex, height and weight. A healthy 60-year-old man at 175 cm and 80 kg has a predicted of about 567 m, with the LLN at about 414 m. Healthy younger adults frequently exceed 600 m.
What 6MWT distance indicates poor prognosis in COPD?
A 6MWT distance under 350 m is associated with poor prognosis in COPD patients across multiple cohort studies and is one component of the BODE index. Distances under 250 m mark severely reduced exercise tolerance and are often part of lung-transplant referral criteria. The 6MWT also tracks pulmonary-rehab response: a 30-metre improvement is the accepted minimal clinically important difference.
How does the 6MWT relate to NYHA class in heart failure?
In chronic CHF, a 6MWT distance under 300 m typically corresponds to NYHA functional class III or IV and predicts higher mortality. Distances over 450 m suggest NYHA I or II. The 6MWT correlates with peak VO2 but is much simpler to perform. It is used in heart-failure clinics to track response to GDMT and cardiac rehabilitation.
How do you prepare for a 6-Minute Walk Test?
Wear comfortable clothing and walking shoes. Use any usual walking aids (cane, walker). Eat lightly two hours before. Avoid vigorous exercise for two hours before. Take usual medications. Rest seated for 10 minutes before the test begins. Avoid warm-ups. The technician records baseline HR, BP, Borg dyspnea, and SpO2 before the timer starts and again at end of test, per ATS 2002 protocol.
What counts as a "stop" during the 6MWT?
A stop is any pause where the patient stands still or sits to rest. The timer keeps running. The number and duration of stops are recorded but do not change the 6-minute interval. Stops indicate exercise intolerance and inform interpretation alongside the distance walked. A test with multiple stops generally signals more severe impairment than the raw distance alone suggests.
Should supplemental oxygen be used during the 6MWT?
If a patient is on chronic oxygen therapy, the test is usually performed with their usual oxygen at the usual flow rate, documented in the report. Comparing oxygen-on vs oxygen-off 6MWT is only done under physician direction. Oxygen-titration trials use the same protocol with different flow rates to find the minimum that prevents desaturation below 88%.
What is the Borg dyspnea scale during 6MWT?
The modified Borg dyspnea scale is a 0-10 self-rating of breathlessness recorded before and immediately after the 6MWT. 0 means no breathlessness; 10 means maximum imaginable. A rise of 3 or more points reflects substantial exertion. Borg leg fatigue is also collected. Both are part of the ATS 2002 standardised report and help distinguish ventilatory vs muscular limitation.
When should the 6MWT not be performed?
Absolute contraindications include unstable angina or myocardial infarction within one month. Relative contraindications include resting HR over 120 bpm, systolic BP over 180 mmHg, diastolic BP over 100 mmHg, or resting SpO2 under 85% on room air without supplementation. The technician stops the test for chest pain, severe dyspnea, leg cramps, diaphoresis, pallor or SpO2 under 80%. Document the reason and time of any termination.